MTOR and central nervous system cancer: Another study shows that KIF3C expression in the low-grade glioma tissue is higher in comparison to the high-grade glioma tissue, and patients with high KIF3C expression have a longer survival time; functionally, KIF3C inhibits glioma cells’ growth through modulating the PI3K/Akt/mTOR pathway [6].